Overview Assessment and Tracking of Long-term Alefacept Safety Status: Terminated Trial end date: 2012-02-01 Target enrollment: Participant gender: Summary Subjects exposed to alefacept are to be enrolled. Subjects will be contacted every 6 months to gather general health information. Details Lead Sponsor: Astellas Pharma IncTreatments: Alefacept